What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to announce the adoption of amendments to HCA Healthcare's bylaws, specifically introducing a new 'proxy access' provision for stockholders and removing outdated provisions related to stockholder action by written consent.

What are the requirements for a stockholder to use the new proxy access right?

To use the proxy access right, a stockholder or a group of up to 20 stockholders must have continuously owned at least 3% of HCA Healthcare's common stock for at least three years. They must also meet other procedural and disclosure requirements outlined in the bylaws.

How does the removal of stockholder action by written consent provisions affect shareholders?

The removal of these provisions is primarily a technical change, reflecting that HCA is no longer under the control of Hercules Holding II. For most shareholders, this change will likely have minimal direct impact on their ability to influence corporate decisions, especially compared to the introduction of proxy access.

What is the significance of the 'proxy access' provision for investors?

The proxy access provision is significant because it potentially empowers long-term, substantial shareholders to nominate their own candidates for the Board of Directors and have those nominations included in HCA's official proxy materials. This can lead to increased shareholder influence over board composition and corporate strategy.

HCA 8-K: Corporate Changes

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on December 21, 2017, to report an amendment to its bylaws, effective December 19, 2017. The primary change is the adoption of a new proxy access provision, allowing eligible stockholders to nominate directors for inclusion in the company's proxy materials. This provision requires a significant ownership stake (3% or more) held for a substantial period (at least three years) by a group of up to 20 stockholders. This amendment signifies a shift in corporate governance, potentially increasing shareholder influence over board composition, especially as the company is no longer controlled by Hercules Holding II. Investors should note the specific thresholds and conditions associated with proxy access, as these will determine the practical impact of this new right on future director elections and overall corporate governance.

Key Highlights

1HCA Healthcare adopted amended and restated bylaws (Second Amended Bylaws) effective December 19, 2017.
2A new 'proxy access' right has been introduced, allowing certain stockholders to nominate director candidates.
3To utilize proxy access, a stockholder or group of up to 20 stockholders must own at least 3% of the company's common stock continuously for a minimum of three years.
4Eligible stockholders can nominate director nominees constituting up to the greater of two or 20% of the Board.
5The new bylaws remove certain provisions for stockholder action by written consent, which are no longer applicable since HCA is no longer controlled by Hercules Holding II.
6The filing also includes the Second Amended and Restated Bylaws as an exhibit.
7This change reflects an evolution in HCA's corporate governance following a period of private control.

HCA Healthcare, Inc. 8-K Report, Bylaw Amendment (Dec 21, 2017)

Summary

Key Highlights

Frequently Asked Questions